Published in J Clin Microbiol on June 29, 2011
Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol (2012) 2.82
Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010). Intensive Care Med (2014) 1.45
Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations. Antimicrob Agents Chemother (2012) 1.44
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol (2012) 1.28
Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. PLoS One (2012) 1.10
A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study. BMC Infect Dis (2013) 0.87
Galectin-3 plays an important role in protection against disseminated candidiasis. Med Mycol (2013) 0.85
Evaluation of blood culture media for the detection of fungi. Eur J Clin Microbiol Infect Dis (2014) 0.84
Comparison of the two blood culture systems, Bactec 9240 and BacT/Alert 3D, in the detection of Candida spp. and bacteria with polymicrobial sepsis. Eur J Clin Microbiol Infect Dis (2012) 0.83
Age and Gender Affect the Composition of Fungal Population of the Human Gastrointestinal Tract. Front Microbiol (2016) 0.83
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study. Ann Intensive Care (2016) 0.81
Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study. Crit Care (2016) 0.80
Invasive Esophageal Candidiasis with Chronic Mediastinal Abscess and Fatal Pneumomediastinum. Am J Case Rep (2016) 0.79
Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study. Antimicrob Agents Chemother (2015) 0.78
Vertebral infection with Candida albicans failing caspofungin and fluconazole combination therapy but successfully treated with high dose liposomal amphotericin B and flucytosine. Med Mycol Case Rep (2014) 0.77
The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med (2017) 0.75
Characterization of Cell Wall Proteins in Saccharomyces cerevisiae Clinical Isolates Elucidates Hsp150p in Virulence. PLoS One (2015) 0.75
High-Resolution Genetics Identifies the Lipid Transfer Protein Sec14p as Target for Antifungal Ergolines. PLoS Genet (2016) 0.75
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study. BMC Infect Dis (2014) 0.75
Comparison of clinical pharmacology of voriconazole and posaconazole. Contemp Oncol (Pozn) (2016) 0.75
Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India. Curr Med Mycol (2016) 0.75
Comparison of BACTEC™ blood culture media for the detection of fungemia. Eur J Clin Microbiol Infect Dis (2016) 0.75
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 18.19
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med (1991) 12.09
Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis (2003) 7.09
The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis (1997) 7.09
Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med (2007) 5.88
Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother (2005) 5.35
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis (2006) 5.27
The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis (2005) 5.25
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol (2004) 4.51
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis (2002) 4.35
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis (2003) 4.29
EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect (2008) 3.75
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol (2005) 3.41
Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis (1999) 3.39
Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis (2004) 3.22
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis (2003) 2.84
Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg (1994) 2.68
Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis (2000) 2.59
The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer (2008) 2.57
Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect (2003) 2.29
Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med (2009) 2.16
Epidemiology of invasive candidiasis. Curr Opin Crit Care (2010) 2.16
National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol (2010) 2.10
Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol (2006) 1.81
Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for candida growth detection. J Clin Microbiol (2004) 1.63
Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol (2006) 1.63
Candidemia in Finland, 1995-1999. Emerg Infect Dis (2003) 1.55
Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol (2005) 1.52
In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection (2002) 1.48
European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect (2002) 1.44
Invasive Candida species infections: a 5 year population-based assessment. J Antimicrob Chemother (2005) 1.43
Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect (2008) 1.38
Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother (2010) 1.34
Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect (2007) 1.32
Active surveillance for candidemia, Australia. Emerg Infect Dis (2006) 1.30
Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. Clin Infect Dis (2008) 1.28
Comparative genotyping of Candida albicans bloodstream and nonbloodstream isolates at a polymorphic microsatellite locus. J Clin Microbiol (2000) 1.27
Retracted Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain. J Clin Microbiol (2010) 1.16
Effect of antifungal therapy timing on mortality in cancer patients with candidemia. Antimicrob Agents Chemother (2009) 1.14
Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect (2005) 1.08
Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care (2009) 1.06
Excess mortality, length of stay and cost attributable to candidaemia. J Infect (2009) 1.04
Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. Pediatr Infect Dis J (2008) 1.02
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother (2009) 1.00
Decreasing candidaemia rate in abdominal surgery patients after introduction of fluconazole prophylaxis*. Clin Microbiol Infect (2010) 0.98
Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008. J Hosp Infect (2010) 0.91
Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007. Diagn Microbiol Infect Dis (2009) 0.90
Candida spp. bloodstream infection: influence of antifungal treatment on outcome. J Antimicrob Chemother (2010) 0.89
Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution. Ann Hematol (2003) 0.89
Typing of Candida isolates from patients with invasive infection and concomitant colonization. Scand J Infect Dis (2010) 0.87
Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors. Mycoses (2005) 0.87
Diagnostics of fungal infections in the Nordic countries: we still need to improve! Scand J Infect Dis (2007) 0.79
Ghost authorship in industry-initiated randomised trials. PLoS Med (2007) 4.95
Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med (2007) 2.85
Quantitative and qualitative usage data of an Internet-based asthma monitoring tool. J Med Internet Res (2004) 2.80
Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis (2006) 2.75
Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci U S A (2011) 2.75
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat Rev Microbiol (2012) 2.50
Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med (2009) 2.13
National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol (2010) 2.10
Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J (2006) 2.07
Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol (2008) 1.88
The clinical impact of bacterial biofilms. Int J Oral Sci (2011) 1.88
Constraints on publication rights in industry-initiated clinical trials. JAMA (2006) 1.82
Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother (2010) 1.82
Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun (2007) 1.81
Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis (2010) 1.73
Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob Agents Chemother (2007) 1.71
Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect Immun (2005) 1.69
Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections. FEMS Immunol Med Microbiol (2010) 1.68
Species identification of clinical isolates of anaerobic bacteria: a comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry systems. J Clin Microbiol (2011) 1.66
Genome analysis of a transmissible lineage of pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet (2013) 1.64
Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol (2003) 1.61
Ten cases of Actinobaculum schaalii infection: clinical relevance, bacterial identification, and antibiotic susceptibility. J Clin Microbiol (2005) 1.61
Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis. J Antimicrob Chemother (2013) 1.60
Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J (2011) 1.59
Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ Microbiol (2010) 1.54
Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol (2005) 1.52
Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients. Pediatr Pulmonol (2003) 1.50
In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J Bacteriol (2007) 1.46
[Epidemic increase in methicillin-resistant Staphylococcus aureus in Copenhagen]. Ugeskr Laeger (2006) 1.41
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob Agents Chemother (2007) 1.40
Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance. J Clin Microbiol (2011) 1.35
Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark. Microb Drug Resist (2008) 1.34
PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother (2011) 1.33
The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation. J Bacteriol (2003) 1.28
Actinobaculum schaalii: a common cause of urinary tract infection in the elderly population. Bacteriological and clinical characteristics. Scand J Infect Dis (2010) 1.28
The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes. Diabetes Care (2004) 1.24
Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine (2010) 1.24
Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J Clin Microbiol (2007) 1.15
Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005. Vaccine (2008) 1.09
Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study. Scand J Infect Dis (2010) 1.03
Molecular screening for Candida orthopsilosis and Candida metapsilosis among Danish Candida parapsilosis group blood culture isolates: proposal of a new RFLP profile for differentiation. J Med Microbiol (2010) 1.03
The prevalence and clinical significance of intestinal parasites in HIV-infected patients in Denmark. Scand J Infect Dis (2010) 1.03
Streptococcus suis: meningitis, spondylodiscitis and bacteraemia with a serotype 14 strain. Scand J Infect Dis (2008) 1.03
Identification of clinically relevant nonhemolytic Streptococci on the basis of sequence analysis of 16S-23S intergenic spacer region and partial gdh gene. J Clin Microbiol (2009) 1.02
Morphological evidence of biofilm formation in Greenlanders with chronic suppurative otitis media. Eur Arch Otorhinolaryngol (2009) 1.02
A Case of Helicobacter cinaedi Bacteraemia in a Previously Healthy Person with Cellulitis. Open Microbiol J (2008) 1.01
Early intervention in 208 Swedish preschoolers with autism spectrum disorder. A prospective naturalistic study. Res Dev Disabil (2011) 1.00
Sensory abnormalities in autism. A brief report. Res Dev Disabil (2010) 0.99
P. aeruginosa in the paranasal sinuses and transplanted lungs have similar adaptive mutations as isolates from chronically infected CF lungs. J Cyst Fibros (2013) 0.99
Six cases of Aerococcus sanguinicola infection: clinical relevance and bacterial identification. Scand J Infect Dis (2008) 0.97
Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease. Cochrane Database Syst Rev (2010) 0.95
Respiratory syncytial virus infection facilitates acute colonization of Pseudomonas aeruginosa in mice. J Med Virol (2009) 0.95
Pseudomonas aeruginosa adaptation to lungs of cystic fibrosis patients leads to lowered resistance to phage and protist enemies. PLoS One (2013) 0.93
Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems. Antimicrob Agents Chemother (2013) 0.92
Recurrent bacteraemia: A 10-year regional population-based study of clinical and microbiological risk factors. J Infect (2009) 0.92
Intranasal immunisation with conjugate vaccine protects mice from systemic and respiratory tract infection with Pseudomonas aeruginosa. Vaccine (2006) 0.92
Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to beta-lactam antibiotics. Clin Microbiol Infect (1996) 0.92
Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis. Antimicrob Agents Chemother (2012) 0.91
Osteitis in the dens of axis caused by Treponema pallidum. BMC Infect Dis (2013) 0.91
First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage. Scand J Gastroenterol (2011) 0.91
Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2012) 0.90
No need for biopsies: comparison of three sample techniques for wound microbiota determination. Int Wound J (2011) 0.90
Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. J Cyst Fibros (2011) 0.90
Leptotrichia amnionii found in septic abortion in Denmark. Scand J Infect Dis (2007) 0.89
Mucosal biofilm detection in chronic otitis media: a study of middle ear biopsies from Greenlandic patients. Eur Arch Otorhinolaryngol (2014) 0.88
Epidemiology of Haemophilus influenzae bacteremia: a multi-national population-based assessment. J Infect (2010) 0.88
Tick-borne encephalitis: a retrospective study of clinical cases in Bornholm, Denmark. Scand J Infect Dis (2003) 0.88
Globicatella sanguinis bacteraemia identified by partial 16S rRNA gene sequencing. Scand J Infect Dis (2007) 0.88
Fever of unknown origin: a retrospective study of 52 cases with evaluation of the diagnostic utility of FDG-PET/CT. Scand J Infect Dis (2011) 0.88
The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis. Am J Rhinol Allergy (2013) 0.88
Autism and developmental profiles in preschoolers: stability and change over time. Acta Paediatr (2013) 0.87
Bacteriocin-mediated competition in cystic fibrosis lung infections. Proc Biol Sci (2015) 0.87
Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2. Infect Immun (2006) 0.87
Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization. J Cyst Fibros (2012) 0.87
Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country. Microb Drug Resist (2011) 0.87
Serotype distribution in non-bacteremic pneumococcal pneumonia: association with disease severity and implications for pneumococcal conjugate vaccines. PLoS One (2013) 0.86
Capnocytophaga cynodegmi peritonitis in a peritoneal dialysis patient. J Clin Microbiol (2007) 0.85
Maternal smoking during pregnancy increases the risk of postnatal infections in preterm neonates. Neonatology (2008) 0.85
Classification of positive blood cultures: computer algorithms versus physicians' assessment--development of tools for surveillance of bloodstream infection prognosis using population-based laboratory databases. BMC Med Res Methodol (2012) 0.85
Infections with beta-haemolytic streptococci: detection by a universal PCR for bacterial DNA and DNA sequencing. Scand J Infect Dis (2008) 0.84
Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand. Int J Antimicrob Agents (2011) 0.84
Molecular characterization of invasive penicillin non-susceptible Streptococcus pneumoniae from Denmark, 2001 to 2005. Scand J Infect Dis (2010) 0.83
Fastidious Gram-Negatives: Identification by the Vitek 2 Neisseria-Haemophilus Card and by Partial 16S rRNA Gene Sequencing Analysis. Open Microbiol J (2010) 0.83
Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients. Future Microbiol (2015) 0.83
CD3+CD8+CD161high Tc17 cells are depleted in HIV-infection. AIDS (2013) 0.83
A managed multidisciplinary programme on multi-resistant Klebsiella pneumoniae in a Danish university hospital. BMJ Qual Saf (2013) 0.83
Non-invasive erythromycin-resistant pneumococcal isolates are more often non-susceptible to more antimicrobial agents than invasive isolates. Int J Antimicrob Agents (2009) 0.82
Ribosomal PCR and DNA sequencing for detection and identification of bacteria: experience from 6 years of routine analyses of patient samples. APMIS (2013) 0.82
PCR and DNA sequencing in establishing the aetiology of bacterial infections in children. APMIS (2008) 0.81
Autism, processing speed, and adaptive functioning in preschool children. ScientificWorldJournal (2013) 0.81
Infective Endocarditis: Identification of Catalase-Negative, Gram-Positive Cocci from Blood Cultures by Partial 16S rRNA Gene Analysis and by Vitek 2 Examination. Open Microbiol J (2010) 0.81
Cellular responses of A549 alveolar epithelial cells to serially collected Pseudomonas aeruginosa from cystic fibrosis patients at different stages of pulmonary infection. FEMS Immunol Med Microbiol (2010) 0.81